Adropin, asprosin, and irisin

Biomarker

1 paper mentions it2 findings

See all 1 papers on adropin, asprosin, and irisin

“No statistically significant differences were found in serum adropin, irisin, and asprosin levels across diabetes status groups (p > 0.05).”
Beyond glycemia: adropin, asprosin, and irisin as potential biomarkers for cardiovascular risk in diabetes and prediabetesScientific reports2026doi:10.1038/s41598-026-37306-3

Effects

2

Framingham risk score

no changein humans1

1 study
  1. Adropin, asprosin, and irisin was not clearly linked with Framingham risk score in humans (healthy, prediabetic, and T2DM individuals).

    “While no direct significant relationship was observed between these biomarkers and FRS”

    Humanshealthy, prediabetic, and T2DM individuals

    Beyond glycemia: adropin, asprosin, and irisin as potential biomarkers for cardiovascular risk in diabetes and prediabetes

    Scientific reports

More on Framingham risk score

Diabetes status

no changein humans1

1 study
  1. Adropin, asprosin, and irisin was not clearly linked with diabetes status in humans (healthy, prediabetic, and T2DM individuals) (p > 0.05).

    “No statistically significant differences were found in serum adropin, irisin, and asprosin levels across diabetes status groups (p > 0.05).”

    Humanshealthy, prediabetic, and T2DM individualsserum

    Beyond glycemia: adropin, asprosin, and irisin as potential biomarkers for cardiovascular risk in diabetes and prediabetes

    Scientific reports

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months